UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 44

of 'Treatment of relapsed or refractory chronic lymphocytic leukemia'

44
TI
Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling.
AU
McMullen JR, Boey EJ, Ooi JY, Seymour JF, Keating MJ, Tam CS
SO
Blood. 2014;124(25):3829.
 
AD
Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia.
PMID